Which genes control the defining features that make us look as we do? And how do they make it happen?
In 1990, University of California San Diego biologist William McGinnis conducted a seminal experiment that helped scientists unravel how high-level control genes called Hox genes shape our appearance features. The McGinnis experiment helped pave the way for understanding the role of Hox genes in determining the uniform appearances of species, from humans to chimpanzees to flies.
Drosophila mimica, a rare fruit fly collected from Hawaii Volcanoes National Park.
McGinnis, a professor emeritus of Cell and Developmental Biology and former dean of the Division of Biological Sciences, helped discover a defining DNA region that he termed the homeobox, a sequence within genes that directs anatomical development. Since the now-famous McGinnis experiment, evolutionary and developmental biologists have pondered how these highly influential Hox genes determine the identities of different body regions.
More than three decades later, a study published Nov. 10 as the featured cover in Science Advances and led by Ankush Auradkar, a UC San Diego postdoctoral scholar mentored by coauthor McGinnis and study senior author Ethan Bier, helps answer questions about how Hox genes function.
The now-textbook McGinnis experiment tested whether the proteins produced by a human or mouse Hox gene could function in flies. Following in these footsteps, the new study leveraged modern CRISPR gene editing to investigate whether all aspects of Hox gene function, which consists of both protein coding and control regions, could be replaced in a common laboratory fruit fly (Drosophila melanogaster) with its counterpart from a rarer Hawaiian cousin (Drosophila mimica), which has a very different face.
The gene in question, proboscipedia, would plainly reveal itself since it directs the formation of strikingly different mouth partssmooth and spongy in D. mel but more grill-like (resembling the face of the alien in Predator science fiction films) in D. mim.
Study coauthor Emily Bulger first collected the notoriously difficult-to-breed D. mim samples from Hawaii Volcanoes National Park, along with the only native fruit (Sapindus saponaria - Hawaiian soapberry) that the insects are known to eat, in order to establish a temporary colony in Biers laboratory. Auradkar then collaborated with coauthor Sushil Devkota to decipher the genome sequence of the D. mim proboscipedia gene, which was nearly 44,000 bases long. The researchers then deleted the D. mel proboscipedia gene and replaced it with the D. mim version of the same.
Electron microscopy images contrast the smooth and spongy features of the common Drosophila melanogaster fruit fly (left) and the grill-like features of its rarer cousin, the Hawaiian Drosophila mimica.
As McGinnis had predicted, the new results revealed that the graceful facial structure of D. mel emerged as the winner over the rough features of D. mim. One trait of D. mim, however, did surface during the experiment: Sensory organs called maxillary palps that stick out from the face in D. mel instead ran parallel to feeding mouthparts as they do in D. mim. Auradkar used sophisticated genetic tools to determine the basis for this difference and tracked it down to a change in the pattern by which the proboscipedia gene is activated (control region changes).
The experiments results help answer longstanding questions about whether Hox genes function as master regulatory genes that dictate different body parts in organisms. Or, as McGinnis proposed, whether Hox genes instead provide abstract positional codes and serve as scaffolds for downstream genes that best benefit the organism. Other than the maxillary palps, the new results demonstrated that McGinnis scaffolding idea proved to be the case.
William McGinnis, professor emeritus of Cell and Developmental Biology.
McGinnis says that beyond the implications for evolutionary biology, the results could help explain developmental issues rooted in fundamental human genetic processes.
These fly studies provide a window into deep evolutionary time and inform us about the mechanisms by which body plans change during evolution, said Bier. These insights may lead to a better of understanding of processes tied to congenital birth defects in humans. With the advent of powerful new CRISPR-based genome editing systems for human therapy on the horizon, new strategies might be formulated to mitigate some of the effects of these often debilitating conditions.
According to Bier, these investigations also provide an example of the intimate connection between the support of basic science and human welfare. The research described in the Science Advances paper was supported by a Paul G. Allen Frontiers Group Distinguished Investigators Award, National Institutes of Health grant R01 GM117321 and a gift from the Tata Trusts in India to the Tata Institute for Genetics and SocietyUniversity of California San Diego (TIGS-UC San Diego). The paper was authored by Ankush Auradkar, Emily Bulger, Sushil Devkota, William McGinnis and Ethan Bier.
Competing interest note: Bier has equity interest in two companies he co-founded: Synbal Inc. and Agragene, Inc., which may potentially benefit from the research results. He also serves on Synbals board of directors and the scientific advisory board for both companies.
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 2nd, 2022
- Growth in Cell and Gene Therapy Market - BioPharm International - October 2nd, 2022
- CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130 for the Treatment of Cutaneous T-Cell... - October 2nd, 2022
- BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA - PR... - October 2nd, 2022
- Fighting Breast and Ovarian Cancer With a Lupus Antibody - Yale School of Medicine - October 2nd, 2022
- This gene therapy company is testing new tech to 'switch off' diabetes and obesity with a pill - Euronews - October 2nd, 2022
- Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Societys 2022 Scientific Sessions - Yahoo Finance - October 2nd, 2022
- Risk of Alzheimer's dementia may be predicted with help of new tool Washington University School of Medicine in St. Louis - Washington University... - October 2nd, 2022
- Tiny Sea Creature's Genes Shed Light on Evolution of Immunity - UPMC - October 2nd, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 2nd, 2022
- Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as... - October 2nd, 2022
- NeuroVoices: Emma Ciafaloni, MD, on the Vast Expansion of Innovative Approaches to Duchenne Muscular Dystrophy - Neurology Live - October 2nd, 2022
- COVID mRNA Jabs and Testing Kicked Off This Industry of Drug Development: Here's What You Need to Know - The Epoch Times - October 2nd, 2022
- Kidney resident macrophages have distinct subpopulations and occupy distinct microenvironments - University of Alabama at Birmingham - October 2nd, 2022
- Nobel Prize for medicine: the full list of winners - The National - October 2nd, 2022
- The surprising link between circadian disruption and cancer may have to do with temperature - EurekAlert - October 2nd, 2022
- The global live cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027 - Yahoo Finance - October 2nd, 2022
- Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy - PR Newswire - September 20th, 2022
- Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector Compositions - Yahoo Finance - September 20th, 2022
- Cholesterol gene mutation: Why would a healthy 27-year-old have severe heart problems? - 69News WFMZ-TV - September 20th, 2022
- Gene Therapy for Severe Hemophilia B Could Be More Cost Effective Than Current Treatments - Managed Healthcare Executive - September 20th, 2022
- AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis... - September 20th, 2022
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 20th, 2022
- Leading Virus Researcher to Chair UVA's Department of Microbiology, Immunology and Cancer Biology - UVA Health Newsroom - September 20th, 2022
- Work remains on Tay-Sachs and other Ashkenazi genetic disorders J. - The Jewish News of Northern California - September 20th, 2022
- Study Shows Genetic Link to Moving to the Beat of Music - Newswise - September 20th, 2022
- Viewpoint: In the post Roe v Wade world, what changes should a biology textbook writer make to address the medical repercussions of Dobbs? - Genetic... - September 20th, 2022
- Alnylam Receives Approval in Europe for AMVUTTRA (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult... - September 20th, 2022
- CSL flexes gene therapy muscle with latest drug - Sydney Morning Herald - September 20th, 2022
- The MIT Press releases new book on the science of the heart from cardiac expert Dr. Sian Harding - EurekAlert - September 20th, 2022
- Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion in 2032: Visiongain Reports Ltd - Yahoo... - September 20th, 2022
- Alzheon Reports Industry-Leading Biomarker, Brain Preservation and Clinical Effects Following 12 Months of Treatment in Phase 2 Trial of Oral ALZ-801... - September 20th, 2022
- Do You Have Lung Cancer With An EGFR Mutation? If So, The Drug Tagrisso Might Be Right For You Based On New Results From A 'Practice Changing' Trial -... - September 20th, 2022
- Getting rid of unwanted transformed cells: Possible new directions in cancer therapy - EurekAlert - September 20th, 2022
- Sven Kili on reconvening with the ISCT - The Medicine Maker - September 14th, 2022
- Study refutes long-held belief that the Corin gene causes hypertension in African Americans - University of Alabama at Birmingham - September 14th, 2022
- Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss - Yahoo... - September 14th, 2022
- Solving medical mysteries with genetics: The Penn Neurogenetics Therapy Center | Penn Today - Penn Today - September 14th, 2022
- Pharmacogenetics Testing in Psychiatry/Depression Market Will Rise at a CAGR 9.5% by 2029 and is segmented by Test Type, Gene Type, Patient Type,... - September 14th, 2022
- Scientists have created a mathematical model for the dynamics of nanoparticles and viruses in cells - EurekAlert - September 14th, 2022
- Fierce Biotech Names ReCode Therapeutics as One of its Fierce 15 Biotech Companies of 2022 - Business Wire - September 14th, 2022
- Foundation Medicine, Relay Therapeutics to Develop FoundationOne CDx for FGFR2 Inhibitor - GenomeWeb - September 14th, 2022
- Downstream Processing in the Age of Precision Medicine: Trends and Challenges - Technology Networks - September 14th, 2022
- BU receives NIH award to increase diversity of STEM and biomedical science workforce - EurekAlert - September 14th, 2022
- Leveraging Best-of-Breed Algorithms for Accuracy in Precision Medicine - BioSpace - September 14th, 2022
- Pitt researchers are leading the way toward a Google Maps of cells - University of Pittsburgh - September 14th, 2022
- The Application of Nanotechnology and Nanomaterials in Cancer Diagnosis and Treatment: A Review - Cureus - September 14th, 2022
- Smart Immune Bolsters Management Team with Medical and Technical Appointments - GlobeNewswire - September 14th, 2022
- A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia - BMC Medicine - BMC Medicine - September 14th, 2022
- dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes - August 15th, 2022
- Cellular & Gene Therapy Guidances | FDA - August 15th, 2022
- The Silver Lining Of Innovation in Genetic Medicine - Pharmaceutical Executive - August 15th, 2022
- FDA Issues Draft Guidance to Facilitate Development of Human Gene Therapy, CAR T Cell, and Regenerative Medicine Products - Wilson Sonsini Goodrich... - August 15th, 2022
- Canadian family raised $3.5M to develop individualized gene therapy for son's rare condition - National Post - August 15th, 2022
- Auburn University researchers first to map blue catfish genome - Office of Communications and Marketing - August 15th, 2022
- Las Vegas baby diagnosed with rare genetic mutation - KVOA Tucson News - August 15th, 2022
- Personalised medicine made in hospitals can revolutionise the way diseases are treated the challenge now will be implementing it - The Conversation... - August 15th, 2022
- 'Guardian of the Genome' and the 'WASp' team up to repair DNA damage - Penn State Health News - August 15th, 2022
- Novartis bid to repurpose rare disease drug for cancer falls short in third trial - BioPharma Dive - August 15th, 2022
- Abnormal protein could be a common link between all forms of motor neurone disease - University of Sydney - August 15th, 2022
- Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - PR Newswire - August 6th, 2022
- FDA halts testing of Beam's base editing cancer therapy - BioPharma Dive - August 6th, 2022
- OHSU advancing first-of-its-kind strategy to overcome infertility - OHSU News - August 6th, 2022
- Viral Vectors Manufacturing Market: Increase in the Number of Gene Therapy Candidates due to Rapid Development of Diseases to Drive the Market -... - August 6th, 2022
- The association of APOE genotype with COVID-19 disease severity | Scientific Reports - Nature.com - August 6th, 2022
- Revolutionizing Healthcare Testing: 1health Unveils Next Generation Diagnostic Platform that Enables Precision Medicine at Scale - Business Wire - August 6th, 2022
- Omega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress - PR Newswire - August 6th, 2022
- Reshaping how doctors and researchers share phenotypic information: first GA4GH standard published by ISO - EurekAlert - August 6th, 2022
- Research Spots Gene That Raises Alzheimer's Risk for Women - HealthDay News - July 4th, 2022
- If You Have This Blood Type, Be Worried About Your Health Eat This Not That - Eat This, Not That - July 4th, 2022
- The NRC HL Holmes Award supports the development of technology to target and treat basal-like breast cancer - National Research Council Canada -... - July 4th, 2022
- UT Health San Antonio on global team discovering Alzheimers clues - San Antonio Report - July 4th, 2022
- Identities in harmony | Penn Today - Penn Today - July 4th, 2022
- The Global Genotyping Market size is expected to reach $30.9 billion by 2028, rising at a market growth of 14.7% CAGR during the forecast period -... - July 4th, 2022
- VA research will bring precision medicine to mental health - VAntage Point - VAntage Point Blog - June 11th, 2022
- Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and... - June 11th, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 11th, 2022
- UC develops new lung cancer treatment | University Of Cincinnati - University of Cincinnati - June 11th, 2022
- CTGT transactions: Beware of ripples in the safe harbor - JD Supra - June 11th, 2022
- Startup offers genetic testing that promises to predict healthiest embryo - WHYY - June 11th, 2022